ArticleMolecular medicine reports2016

Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis.

Dandan Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.